Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are aged between 50 and 85 years old
- People who have been newly diagnosed with diabetes based on blood sugar test results, where the diagnosis was made within the last 180 days (about 6 months) before joining the trial
- People whose diabetes diagnosis, combined with certain health factors, results in a score of 3 or higher on a specific risk assessment tool used to identify people who may benefit from pancreatic cancer screening (confirm with trial site)
- People who are willing and able to give their consent to take part in the trial, either in writing or through a remote process
Who may not be able to join:
- People who have already been diagnosed with pancreatic ductal adenocarcinoma (a specific type of pancreatic cancer)
- People who have a known inherited genetic condition that increases cancer risk, such as BRCA1/2 gene mutations, Lynch syndrome, or Peutz-Jeghers syndrome
- People who have previously had surgery on their pancreas
- People who are already being monitored for cysts on their pancreas at the time of joining the trial
- People for whom a contrast-enhanced CT scan (a type of detailed X-ray using a special dye) would not be considered safe or appropriate based on standard medical guidelines at the time of joining
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ajit H. Goenka, MD, Mayo Clinic in Rochester
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment yield (Feasibility); Imaging adherence rates (Feasibility); Blood collection success rates (Feasibility); Completeness of electronic medical record (EMR)-based follow-up (Feasibility)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.